Eversept Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
182,894
+65,881
+56% +$3.07M 0.57% 45
2026
Q1
$4.23M Sell
117,013
-666,776
-85% -$27.9M 0.22% 64
2025
Q4
$36.9M Buy
783,789
+96,660
+14% +$4.08M 1.86% 15
2025
Q3
$22.3M Sell
687,129
-152,155
-18% -$5.42M 1.54% 19
2025
Q2
$34.6M Buy
839,284
+340,077
+68% +$13.1M 3.18% 9
2025
Q1
$20.8M Buy
499,207
+264,273
+112% +$13.7M 2.12% 16
2024
Q4
$13.8M Buy
+234,934
New +$13.9M 1.22% 20

Other funds holding BRKR

Eversept Partners's BRKR Position: Q2 2026 in Review

Eversept Partners increased its Bruker (BRKR) stake by 56% in Q2 2026, buying an estimated $3.07M and bringing the position to 182,894 shares worth $11M. The position accounts for 0.57% of the portfolio, ranked #45.

Eversept Partners first reported a position in BRKR in Q4 2024 and has held it in 7 quarters since. The position peaked at $36.9M in Q4 2025. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Eversept Partners held 182,894 shares of Bruker worth $11M as of Q2 2026.
  • Eversept Partners bought 65,881 Bruker shares in Q2 2026, an estimated $3.07M.
  • Bruker made up 0.57% of Eversept Partners's portfolio in Q2 2026, its #45 holding.
  • Eversept Partners first reported a position in Bruker in Q4 2024 and has held it in 7 quarters since.
  • Eversept Partners's Bruker position peaked at $36.9M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.